Pfizer Announces $650 Million Manufacturing Technology Centre in Connecticut

Pfizer announced a $650 million investment on 5 November for a new manufacturing technology centre at its Groton, Connecticut, research and development campus. The planned facility will cover approximately 220,000 square feet and support production of clinical active pharmaceutical ingredients and drug products, with operations expected to begin around mid-2031. The investment creates opportunities for pharmaceutical equipment suppliers, laboratory technology providers, construction firms and specialist technical-service companies. HPC can support supplier identification, healthcare-sector partnerships and project procurement research.